SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma

Clinical Cancer Research

Volumn 17, Issue 2, 2011, Pages 247-254

  Kunst, Henricus P M ^a,b   Rutten, Martijn H ^a   De Mönnink, Jan Pieter ^d   Hoefsloot, Lies H ^a   Timmers, Henri J L M ^a   Marres, Henri A M ^a   Jansen, Jeroen C ^e   Kremer, Hannie ^a,b,c   Bayley, Jean Pierre ^e   Cremers, Cor W R J ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MÁXIMA MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE F2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HEAD AND NECK TUMOR; HEREDITARY HEAD AND NECK PARAGANGLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARAGANGLIOMA; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; FEMALE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASTIC SYNDROMES, HEREDITARY; PARAGANGLIOMA; PEDIGREE; PROTEIN SUBUNITS; SUCCINATE DEHYDROGENASE;

EID: 79251468798     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-0420     Document Type: Article

References (31)

1. Lack E.E. Tumors of the Adrenal Gland and Extra-adrenal Paraganglia. Atlas of human Pathology: Washington, Armed forces Institue of Pathology 1997.
2. Martin TP. What we call them: the nomenclature of head and neck paragangliomas. Clin Otolaryngol 2006;31:185-6.
3. van Baars F, Van Den BP, Cremers C, Veldman J. Familial nonchromaffinic paragangliomas (glomus tumors) : clinical aspects. Laryngoscope 1981;91:988-96.
4. Chase W. Familial and bilateral tumours of the carotic body. J Pathol Bacteriol 1933;36:1-12.
5. Drovdlic CM, Myers EN, Peters JA, Baysal BE, Trackman DE, Slattery WH 3rd, et al. Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope 2001;111:1822-7.
6. Van Der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 1989;2:1291-4.
7. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54.
8. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-51.
9. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268-70.
10. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009;325:1139-42.
11. Burnichon N, Brière JJ, Libé R, Vescovo L, Rivière J, Tissier F, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010;19:3011-20.
12. Mariman EC, Van Beersum SE, Cremers CW, van Baars FM, Ropers HH. Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q. Hum Genet 1993;91:357-61.
13. Hensen EF, Jordanova ES, van Minderhout IJ, Hogendoorn PC, Taschner PE, van der Mey AG, et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 2004;23:4076-83.
14. Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A, et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A 2008;105:12417-22.
15. Lee JH, Barich F, Karnell LH, Robinson RA, Zhen WK, Gantz BJ, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 2002;94:730-7. (Pubitemid 34132302)
16. Boedeker CC, Neumann HP, Maier W, Bausch B, Schipper J, Ridder GJ. Malignant head and neck paragangliomas in SDHB mutation carriers. Otolaryngol Head Neck Surg 2007;137:126-9.
17. Struycken PM, Cremers CW, Mariman EC, Joosten FB, Bleker RJ. Glomus tumours and genomic imprinting: influence of inheritance along the paternal or maternal line. Clin Otolaryngol Allied Sci 1997;22:71-6.
18. Mariman EC, Van Beersum SE, Cremers CW, Struycken PM, Ropers HH. Fine mapping of a putatively imprinted gene for familial nonchromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity. Hum Genet 1995;95:56-62.
19. van Baars F, Cremers C, Van Den BP, Geerts S, Veldman J. Genetic aspects of nonchromaffin paraganglioma. Hum Genet 1982; 60:305-9.
20. Young WF Jr. Paragangliomas: clinical overview. Ann N Y Acad Sci 2006;1073:21-9.
21. Jansen JC, Van Den BR, Kuiper A, Van Der Mey AG, Zwinderman AH, Cornelisse CJ. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer 2000;88:2811-6.
22. Kunst D, Kremer H, Cremers C. Inherited diseases: miscellaneous paraganglioma. In Genetics For ENT Specialists. Nijmegen, the Netherlands: Remedica;2005:p.165-71.
23. Netterville JL, Jackson CG, Miller FR, Wanamaker JR, Glasscock ME. Vagal paraganglioma: a review of 46 patients treated during a 20-year period. Arch Otolaryngol Head Neck Surg 1998;124:1133-40.
24. Smit AA, Timmers HJ, Wieling W, Wagenaar M, Marres HA, Lenders JW, et al. Long-term effects of carotid sinus denervation on arterial blood pressure in humans. Circulation 2002;105:1329-35.
25. Hallett JW Jr., Nora JD, Hollier LH, Cherry KJ Jr., Pairolero PC. Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas: a fifty-year experience with 153 tumors . J Vasc Surg 1988;7:284-91.
26. Baysal BE. Clinical and molecular progress in hereditary paraganglioma. J Med Genet 2008 ;45:689-94.
27. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-51.
28. Havekes B, Corssmit EP, Jansen JC, Van Der Mey AG, Vriends AH, Romijn JA. Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab 2007;92:1245-8.
29. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006;91:827-36.
30. Niemann S, Muller U, Engelhardt D, Lohse P. Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC. Hum Genet 2003;113:92-4. (Pubitemid 36869043)
31. Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, Pacak K. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer 2009;16:391-400.